NCT00052845 Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00051571 Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma Status COMPLETED Phase PHASE2
NCT00050167 Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer Status COMPLETED Phase PHASE1
NCT00049296 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00049283 Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00049088 Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00047840 This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. Status COMPLETED Phase PHASE2
NCT00047255 Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT00047099 Combination Chemotherapy in Treating Women With Breast Cancer Status COMPLETED Phase PHASE3
NCT00046826 Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy Status COMPLETED Phase PHASE2
NCT00045448 Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00045227 Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00044993 Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00043576 ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere Status UNKNOWN Phase PHASE2/PHASE3
NCT00042939 Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00042835 Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00041171 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Status WITHDRAWN Phase PHASE3
NCT00041093 Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT00041067 S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2